Results 161 to 170 of about 12,555 (213)

Nomadic Lactobacilli as cell factory for antibiofilm therapy. [PDF]

Front Cell Infect Microbiol
Paul LS, Hameed HC, K V L, Sharma A, Lee J, Shemesh M, Rajasekharan SK.   +6 more
europepmc   +1 more source

Identification and antifungal susceptibility pattern of Candida species isolated from a tertiary hospital in Irrua, Edo State, Nigeria. [PDF]

BMC Microbiol
Olowosile FI, Ogefere HO, Ibadin EE, Samuel SO, Okoeguale J, Omorogbe FI, Ashe CA.   +6 more
europepmc   +1 more source

Exploring the relationship between threatened abortion and vaginal microbiota: A retrospective study. [PDF]

Medicine (Baltimore)
Liu T, Xiao D, Jiang T, Qu X, Su Z, Zhou Y.   +5 more
europepmc   +1 more source

Ketoprofen-loaded quatsomes as a smart repurposed antifungal therapy for vaginal infections: formulation, characterization, and microbiological evaluation. [PDF]

Front Pharmacol
Eldeeb AE, Aziz DE, Hassan M, Saher O, Ahmed S.   +4 more
europepmc   +1 more source

Species Distribution, Characterization, and Antifungal Susceptibility Patterns of <i>Candida</i> Isolates Causing Oral and Vulvovaginal Candidiasis in Chile. [PDF]

Antibiotics (Basel)
Nahuelcura F, Duarte EÁ.
europepmc   +1 more source

Study on the impact of biofilm formation by <i>Candida albicans</i> in recurrent vulvovaginal candidiasis on drug susceptibility. [PDF]

Front Cell Infect Microbiol
Li S, Shen Z, Wang S, Peng Y, Qi W.
europepmc   +1 more source

The pathogenicity and future treatment strategies of <i>Candida albicans</i>. [PDF]

Front Cell Infect Microbiol
Wu J, Jiang C, Wang H, Chen T, Chen X, Da W.   +5 more
europepmc   +1 more source

Vulvodynia (chronic vulval pain).

BMJ
Braunstein M, Sheinis M, Laktabai J, Selk A.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recurrent Vulvovaginal Candidiasis

New England Journal of Medicine, 1986
Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in women in all strata of society affecting millions of women worldwide. Previously, RVVC occurrence was limited by onset of menopause but the widespread use of hormone replacement therapy has extended the at-risk period.
Jack D Sobel
openaire   +4 more sources